Search Results for: health

By Kuldip K. Ambastha Per the table seen above, the Dow Jones Industrial Average (DJIA) took investors on a volatile ride this week. Down days were seen on Monday and Friday. Up days were seen on the Tuesday, Wednesday, and Thursday in between. This pattern in the DJIA was observed due to the federal government’s …

Continue reading “Government Stimulus and the Dow Jones – Week of March 23-27, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 25, 2020, the stock of Moderna, Inc. (MRNA) rose by 27.8% for the day. As the coronavirus (COVID-19) has spread around the world and led to a sell-off in the capital markets, Moderna, Inc. announced that its coronavirus vaccine candidate is scheduled to be …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 24-28, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha HAPPY HOLIDAYS, EVERYBODY! During this week of Christmas, Peloton Interactive, Inc. (PTON) and WW International, Inc. (formerly Weight Watchers International, Inc.) (WW) caught our eye. On Thursday, December 26, 2019 (the day after Christmas 2019), Peloton dropped by 6.1%, while WW International fell by 8.5%. Peloton is …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 23-27, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 21-25, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 9-13, 2019”

By Anil K. Ambastha and Kuldip K. Ambastha After testimony of the U.S. Federal Reserve Chairman Jerome Powell to the U.S. Congress where he indicated the possibility that the central bank may cut interest rates during its meeting later this month, some of the major stock market indices reached their all-time highs. The S&P 500, …

Continue reading “What Caught Our Attention in the Investment World? – Week of July 8-12, 2019”